⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ICCM News
IceCure Medical Ltd. Ordinary Shares
IceCure Medical to Report Third Quarter 2025 Financial and Operating Results on November 19, 2025
prnewswire.com
ICCM
IceCure Promotes Shay Levav to Chief Operating Officer as Company Ramps up for Increased Commercial Traction
prnewswire.com
ICCM
IceCure's Cryoablation System Combined with Radiation Therapy Successfully Treats Non-Small Cell Lung Cancer (NSCLC) with 92% Disease-Specific 5-year Survival
prnewswire.com
ICCM
IceCure's ProSense® Showcased at TME Fall Summit: "Take the Lead in Breast Cancer Care" Roundtable Highlighting Cryoablation Advances
prnewswire.com
ICCM
ICCM
IceCure Medical to Attend the 2025 Maxim Growth Summit
prnewswire.com
ICCM
ICCM
IceCure Medical's ProSense® Cryoablation Granted FDA Marketing Authorization for Treatment of Low-Risk Breast Cancer in Women Aged 70 and Above: Significant Development in Giving Women with Breast Cancer Minimally Invasive Care
prnewswire.com
ICCM
ICCM
IceCure's ProSense® at the European Society of Breast Imaging Congress 2025: Unlocking De-Escalation of Care in Breast Cancer, Positive Results from 5 Independent Studies Presented
prnewswire.com
ICCM
ICCM
IceCure's ProSense® Featured at CIRSE 2025 Annual Meeting: Positive Clinical Results with Cryoablation from 4 Independent Studies Presented
prnewswire.com
ICCM
ICCM
IceCure Granted Notice of Allowance for U.S. Patent for its Next-Generation XSense™ Cryoprobes
prnewswire.com
ICCM
ICCM
Cancer Immunotherapy Surge Drives $258B Market as FDA Accelerates Approvals
prnewswire.com
ONCY
ANIX
ICCM
IBRX
REGN
ONCY
ANIX
ICCM
IBRX
REGN